Related Experiment Video

Updated: Jun 8, 2025

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
05:07

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

6.6K

An Insight into the Structure-activity Relationship of Benzimidazole and Pyrazole Derivatives as Anticancer Agents

Shital M Patil1, Piyush Nikalje1, Navnath Gavande2,3

  • 1Department of Chemistry, AISSMS College of Pharmacy, Kennedy Road, Pune-01, India.

Current Topics in Medicinal Chemistry
|November 1, 2024
PubMed
Abstract

Insights

Structure-activity relationship studies guide the development of novel benzimidazole and pyrazole hybrids. Optimizing these anticancer agents enhances potency and selectivity against cancer cells.

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Organic Synthesis

Background:

  • Cancer remains a major global health challenge, necessitating novel therapeutic strategies.
  • Benzimidazole and pyrazole derivatives show promise as anticancer agents but face challenges like resistance and toxicity.
  • Optimizing these scaffolds through structure-activity relationships (SAR) is crucial for improved efficacy.

Purpose of the Study:

  • To review benzimidazole, pyrazole, and their hybrid derivatives for anticancer activity.
  • To focus on structure-activity relationships (SAR) of these compounds.
  • To compile findings on potent and least potent derivatives.

Main Methods:

  • Literature review and analysis of benzimidazole and pyrazole derivatives.
  • Examination of SAR for various cancer targets and cell lines.
  • Summarization of substitutions to identify an optimized pharmacophore.

Main Results:

  • Analysis of existing studies provides insights into SAR of benzimidazole and pyrazole derivatives.
  • Identified key structural features influencing anticancer activity.
  • Anticipated guidance for researchers in designing potent anticancer agents.

Conclusions:

  • Structure-activity relationship (SAR) studies are vital for developing effective anticancer drugs.
  • Pyrazole-benzimidazole hybrids offer potential for enhanced potency and selectivity.
  • SAR-driven design can lead to more targeted cancer therapies.
Keywords:
AnticancerBenzimidazoleCancer cellsHybrid derivativesPyrazoleStructural Activity Relationship (SAR)

More Related Videos

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

13.9K
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.5K

Related Concept Videos

Basicity of Heterocyclic Aromatic Amines01:25

Basicity of Heterocyclic Aromatic Amines

Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
5.7K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
227
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
611
Structure of Benzene: Kekulé Model01:07

Structure of Benzene: Kekulé Model

In 1865, August Kekule suggested the structure of benzene according to the structural theory of organic chemistry based on the three assertions—formula of benzene is C6H6, all the hydrogens of benzene are equivalent, and each carbon must have four bonds due to its tetravalency.
He proposed that benzene has a cyclic structure of six carbon atoms attached to one hydrogen atom each, with three alternating pi bonds.
8.6K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
175